Liver transplant recipients with hepatitis B may need lifelong antiviral treatment
Sunday, March 1, 2009 - 09:15
in Health & Medicine
Patients who undergo liver transplantation for hepatitis B-related liver damage should receive lifelong antiviral treatment to keep the disease from coming back. A new study shows that they lack cellular immunity against the disease, making recurrence likely if antiviral treatment is withdrawn. These findings are in the March issue of Liver Transplantation, a journal published by John Wiley and Sons. The article is also available online at Wiley Interscience...